PLoS ONE (Jan 2012)

Possible role of the WDR3 gene on genome stability in thyroid cancer patients.

  • Wilser Andrés García-Quispes,
  • Susana Pastor,
  • Pere Galofré,
  • Josefina Biarnés,
  • Joan Castell,
  • Antonia Velázquez,
  • Ricard Marcos

DOI
https://doi.org/10.1371/journal.pone.0044288
Journal volume & issue
Vol. 7, no. 9
p. e44288

Abstract

Read online

The role of the WDR3 gene on genomic instability has been evaluated in a group of 115 differentiated thyroid cancer (DTC) patients. Genomic instability has been measured according to the response of peripheral blood lymphocytes to ionizing radiation (0.5 Gy). The response has been measured with the micronucleus (MN) test evaluating the frequency of binucleated cells with MN (BNMN), both before and after the irradiation. No differences between genotypes, for the BNMN frequencies previous the irradiation, were observed. Nevertheless significant decreases in DNA damage after irradiation were observed in individuals carrying the variant alleles for each of the three genotyped SNPs: rs3754127 [-8.85 (-15.01 to -2.70), P<0.01]; rs3765501 [-8.98 (-15.61 to -2.36), P<0.01]; rs4658973 [-8.70 (-14.94 to -2.46), P<0.01]. These values correspond to those obtained assuming a dominant model. This study shows for the first time that WDR3 can modulate genome stability.